UA54103A - Способ восстановления внутрикишечной флоры у пациентов с острым деструктивным панкреатитом в раннем послеоперационном периоде - Google Patents
Способ восстановления внутрикишечной флоры у пациентов с острым деструктивным панкреатитом в раннем послеоперационном периоде Download PDFInfo
- Publication number
- UA54103A UA54103A UA2002053933A UA200253933A UA54103A UA 54103 A UA54103 A UA 54103A UA 2002053933 A UA2002053933 A UA 2002053933A UA 200253933 A UA200253933 A UA 200253933A UA 54103 A UA54103 A UA 54103A
- Authority
- UA
- Ukraine
- Prior art keywords
- patients
- day
- early postoperative
- microbial flora
- acute
- Prior art date
Links
- 206010033645 Pancreatitis Diseases 0.000 title abstract description 14
- 238000000034 method Methods 0.000 title abstract description 14
- 230000001154 acute effect Effects 0.000 title abstract description 11
- 230000001066 destructive effect Effects 0.000 title abstract description 9
- 230000000968 intestinal effect Effects 0.000 title abstract description 9
- 230000002980 postoperative effect Effects 0.000 title abstract description 8
- 230000000813 microbial effect Effects 0.000 title abstract 2
- 238000011084 recovery Methods 0.000 title abstract 2
- RCIMBBZXSXFZBV-UHFFFAOYSA-N piromidic acid Chemical compound N1=C2N(CC)C=C(C(O)=O)C(=O)C2=CN=C1N1CCCC1 RCIMBBZXSXFZBV-UHFFFAOYSA-N 0.000 abstract description 7
- 239000006041 probiotic Substances 0.000 abstract description 4
- 230000000529 probiotic effect Effects 0.000 abstract description 4
- 235000018291 probiotics Nutrition 0.000 abstract description 4
- 229960002181 saccharomyces boulardii Drugs 0.000 abstract 1
- 206010033647 Pancreatitis acute Diseases 0.000 description 5
- 201000003229 acute pancreatitis Diseases 0.000 description 5
- 229940124350 antibacterial drug Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 210000000813 small intestine Anatomy 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 4
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000002604 ultrasonography Methods 0.000 description 4
- 208000027244 Dysbiosis Diseases 0.000 description 3
- 230000007140 dysbiosis Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 206010070545 Bacterial translocation Diseases 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000007375 bacterial translocation Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 229940109239 creatinine Drugs 0.000 description 2
- 230000000741 diarrhetic effect Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 244000005709 gut microbiome Species 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 206010024378 leukocytosis Diseases 0.000 description 2
- 210000002747 omentum Anatomy 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000036387 respiratory rate Effects 0.000 description 2
- 238000011477 surgical intervention Methods 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 208000007848 Alcoholism Diseases 0.000 description 1
- 208000036649 Dysbacteriosis Diseases 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 206010001584 alcohol abuse Diseases 0.000 description 1
- 208000025746 alcohol use disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 229960000484 ceftazidime Drugs 0.000 description 1
- NMVPEQXCMGEDNH-TZVUEUGBSA-N ceftazidime pentahydrate Chemical compound O.O.O.O.O.S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)NC(=O)\C(=N/OC(C)(C)C(O)=O)C=2N=C(N)SC=2)CC=1C[N+]1=CC=CC=C1 NMVPEQXCMGEDNH-TZVUEUGBSA-N 0.000 description 1
- 229960004755 ceftriaxone Drugs 0.000 description 1
- VAAUVRVFOQPIGI-SPQHTLEESA-N ceftriaxone Chemical compound S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1CSC1=NC(=O)C(=O)NN1C VAAUVRVFOQPIGI-SPQHTLEESA-N 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 210000000574 retroperitoneal space Anatomy 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 238000012876 topography Methods 0.000 description 1
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 description 1
- 229960001082 trimethoprim Drugs 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Способ восстановления внутрикишечной флоры у пациентов с острым деструктивным панкреатитом в раннем послеоперационном периоде состоит в применении противобактериального препарата. Используют пробиотик Энтерол 250 (Saccharomyces boulardii), который вводят на протяжении 14 суток непосредственно в полость тонкой кишки через еюностому.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UA2002053933A UA54103A (ru) | 2002-05-14 | 2002-05-14 | Способ восстановления внутрикишечной флоры у пациентов с острым деструктивным панкреатитом в раннем послеоперационном периоде |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UA2002053933A UA54103A (ru) | 2002-05-14 | 2002-05-14 | Способ восстановления внутрикишечной флоры у пациентов с острым деструктивным панкреатитом в раннем послеоперационном периоде |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA54103A true UA54103A (ru) | 2003-02-17 |
Family
ID=74305915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA2002053933A UA54103A (ru) | 2002-05-14 | 2002-05-14 | Способ восстановления внутрикишечной флоры у пациентов с острым деструктивным панкреатитом в раннем послеоперационном периоде |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA54103A (ru) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102012109727A1 (de) | 2011-11-23 | 2013-05-23 | Vadim Kozolovskyi | Enterosorbenszusammensetzung |
-
2002
- 2002-05-14 UA UA2002053933A patent/UA54103A/ru unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102012109727A1 (de) | 2011-11-23 | 2013-05-23 | Vadim Kozolovskyi | Enterosorbenszusammensetzung |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Debenham | Ulcer of the cecum during oxyphenbutazone (tandearil) therapy. | |
| TW202110474A (zh) | 含溶菌酶之寬譜抗菌醫藥配方及其使用方法 | |
| Andreev et al. | Adhesive disease of the abdominal cavity | |
| Mahir et al. | Giant phytobezoar; an unusual cause of gastric outlet obstruction: A case report with literature review | |
| US20050137265A1 (en) | Rapidly dissolving metoclopramide solid oral dosage and method thereof | |
| UA54103A (ru) | Способ восстановления внутрикишечной флоры у пациентов с острым деструктивным панкреатитом в раннем послеоперационном периоде | |
| Hall et al. | Acute hematogenous osteomyelitis | |
| Soylu et al. | Causes and management of urinary system problems in children on long‐term home invasive mechanical ventilation | |
| GB1585863A (en) | Pharmaceutical lactobacillus preparations | |
| RU2187318C2 (ru) | Способ лечения хронического гастрита и язвенной болезни двенадцатиперстной кишки | |
| Tenlik et al. | Short and long-term safety and durability of PEG-J tube in jejunal levodopa infusion in patients with Parkinson's disease | |
| RU2694549C1 (ru) | Способ ведения детей с болезнью Гиршпрунга в периоперационном периоде | |
| UA71470A (ru) | Способ селективной коррекции внутрикишечного гомеостаза у пациентов с гнойно-воспалительными поражениями органов панкреато-билиарной зоны | |
| Aghdam et al. | Investigating the Effectiveness of Ketorolac in Controlling Pain after Abdominal Surgeries | |
| RU2344825C1 (ru) | Способ профилактики спаечной кишечной непроходимости при перитоните | |
| UA62152A (en) | Method for decreasing volume of intestinal evacuations and restoring intestinal microflora in patients with ileostoma at early postoperative stage | |
| UA10025U (en) | Method for preventing early postoperative gastrointestinal bleeding in patients fed enterally | |
| UA8867U (en) | Method for preventing pyo-septical complications of acute pancreatitis | |
| Changtai et al. | Current drug therapy in ulcerative colitis. | |
| UA111593U (uk) | Спосіб корекції внутрішньо-кишкового гомеостазу та відновлення імунного захисту у пацієнтів з дисбіотичними порушеннями мікрофлори шлунково-кишкового тракту | |
| UA61449A (en) | Method for preventing postoperative peritoneal adhesions | |
| UA111483U (uk) | Спосіб профілактики порушень внутрішньо-кишкового гомеостазу та кишкового дисбіозу при проведенні тривалої антибактеріальної терапії | |
| Mekić et al. | Our experiences in treatment of patients suffering from rheumatoid arthritis | |
| UA18859U (en) | Method for preventing development of acute erosions and ulcers of gastric and intestinal mucosa early in postoperative period in patients with acute destructive pancreatitis | |
| UA35480A (ru) | Способ лечения спаечной непроходимости |